SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-221930
Filing Date
2012-05-09
Accepted
2012-05-09 15:56:35
Documents
10
Period of Report
2012-05-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d350031d8k.htm 8-K 35132
2 INDENTURE, DATED AS OF MAY 9,2012 d350031dex41.htm EX-4.1 709819
3 FORM OF GLOBAL UNIT d350031dex42.htm EX-4.2 96795
4 FORM OF EXCHANGE AND PURCHASE AGREEMENT d350031dex101.htm EX-10.1 62520
5 PLEDGE AND SECURITY AGREEMENT d350031dex102.htm EX-10.2 179067
6 WARRANT AGREEMENT d350031dex103.htm EX-10.3 209186
7 PRESS RELEASE d350031dex991.htm EX-99.1 11287
8 PRESS RELEASE d350031dex992.htm EX-99.2 10963
9 GRAPHIC g350031g30a02.jpg GRAPHIC 10022
10 GRAPHIC g350031g55s40.jpg GRAPHIC 7082
  Complete submission text file 0001193125-12-221930.txt   1340081
Mailing Address ONE TOWER CENTER EAST BRUNSWICK NJ 08816
Business Address ONE TOWER CENTER EAST BRUNSWICK NJ 08816 7324189300
SAVIENT PHARMACEUTICALS INC (Filer) CIK: 0000722104 (see all company filings)

IRS No.: 133033811 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15313 | Film No.: 12825607
SIC: 2833 Medicinal Chemicals & Botanical Products